Tenaya Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TNYA research report →
Companywww.tenayatherapeutics.com
Tenaya Therapeutics, Inc. , a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms.
- CEO
- Faraz Ali
- IPO
- 2021
- Employees
- 97
- HQ
- South San Francisco, CA, US
Price Chart
Valuation
- Market Cap
- $134.52M
- P/E
- -1.49
- P/S
- 597.85
- P/B
- 1.16
- EV/EBITDA
- -0.82
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 144.89%
- Op Margin
- -38159.11%
- Net Margin
- -36891.11%
- ROE
- -80.56%
- ROIC
- -70.72%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-90,597,000 · 18.48%
- EPS
- $-0.59 · 54.96%
- Op Income
- $-93,331,000
- FCF YoY
- 24.74%
Performance & Tape
- 52W High
- $2.35
- 52W Low
- $0.39
- 50D MA
- $0.77
- 200D MA
- $1.03
- Beta
- 2.77
- Avg Volume
- 4.73M
Get TickerSpark's AI analysis on TNYA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 18, 26 | Ali Faraz | sell | 3,390 |
| May 18, 26 | Tingley Whittemore | sell | 3,121 |
| May 18, 26 | Higa Tomohiro | sell | 1,485 |
| Feb 24, 26 | COLUMN GROUP III GP, LP | sell | 349,212 |
| Feb 24, 26 | COLUMN GROUP III GP, LP | sell | 309,228 |
| Feb 25, 26 | COLUMN GROUP III GP, LP | sell | 1,862,545 |
| Feb 20, 26 | COLUMN GROUP III GP, LP | sell | 277,769 |
| Feb 23, 26 | COLUMN GROUP III GP, LP | sell | 162,291 |
| Feb 20, 26 | COLUMN GROUP III GP, LP | sell | 245,965 |
| Feb 23, 26 | COLUMN GROUP III GP, LP | sell | 143,709 |
Our TNYA Coverage
We haven't published any research on TNYA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TNYA Report →